Search Results 311-320 of 17115 for pharmacogenetics
The purpose of this study is to characterize the immunophenotype of individuals with hypereosinophilia-associated cardiovascular, gastrointestinal, hematologic, ...
In this study, we make and test preclinical models of gynecological cancers (ovarian, fallopian tube, peritoneal, uterine, vulvar, cervix, and vaginal) of any ...
The primary objective of this study is to evaluate mean change in best-corrected visual acuity (BCVA) of RGX-314 relative to ranibizumab at Week 38. Second ...
Cholangiocarcinoma (CCA) is an aggressive cancer that forms in the cells that line the bile duct. The only treatment options include aggressive chemotherapy ...
About this study. The purpose of this study is to evaluate clinical complications, pattern of kidney function decline and identification of clinical ...
Our core offers services to support research and clinical trials, including next-generation sequencing, gene mutation analysis and sample biobanking. Overview.
The purpose of this study is to evaluate the safety [including dose-limiting toxicities (DLTs)] of the combination therapy of TILT-123 and pembrolizumab in ...
Inclusion Criteria: Signed written informed consent must be obtained and documented according to International Conference on Harmonization (ICH)- Good ...
Giving more than one drug (combination chemotherapy) may kill more tumor cells. Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized ...
Earlier detection of women's vascular health issues can affect heart disease risk, Mayo Clinic study · Science Saturday: Restoring function with larynx ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!